Corbenic Partners LLC Ionis Pharmaceuticals Inc Transaction History
Corbenic Partners LLC
- $380 Million
- Q2 2022
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
398Shares Held
122MCall Options Held
854KPut Options Held
464K-
Vanguard Group Inc Valley Forge, PA13.4MShares$619 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$614 Million0.35% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$450 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$383 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$263 Million0.04% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.54B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...